Krystal Biotech Inc Cash Flow Quality Index
Krystal Biotech Inc cash flow quality index. Krystal Biotech Inc (KRYS) has a Cash Flow Quality Index of 1.37x as of June 2026. Operating cash flow of $74.79 Million exceeds net income of $54.77 Million, indicating high earnings quality where cash backs reported profits. See Krystal Biotech Inc (KRYS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Krystal Biotech Inc (2023–2025)
Cash flow quality index of Krystal Biotech Inc from 2023 to 2025. Historical Cash Flow Quality Index for Krystal Biotech Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore KRYS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Krystal Biotech Inc Cash Flow Quality Index by Year (2023–2025)
Krystal Biotech Inc cash flow quality index by year from 2023 to 2025. Year-by-year earnings quality comparison for Krystal Biotech Inc. For the full cash flow conversion analysis, see Krystal Biotech Inc cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.98x | $200.87 Million | $204.83 Million | ▼ -29.2% |
| 2024 | 1.38x | $123.42 Million | $89.16 Million | ▲ +117.0% |
| 2023 | -8.12x | $-88.80 Million | $10.93 Million | — |